HK1026148A1 - Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation. - Google Patents

Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation.

Info

Publication number
HK1026148A1
HK1026148A1 HK00105485A HK00105485A HK1026148A1 HK 1026148 A1 HK1026148 A1 HK 1026148A1 HK 00105485 A HK00105485 A HK 00105485A HK 00105485 A HK00105485 A HK 00105485A HK 1026148 A1 HK1026148 A1 HK 1026148A1
Authority
HK
Hong Kong
Prior art keywords
preparation
preparing
water
active principle
highly insoluble
Prior art date
Application number
HK00105485A
Other languages
English (en)
Inventor
Giovanni Cavallo
Lenonardo Marchitto
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of HK1026148A1 publication Critical patent/HK1026148A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK00105485A 1997-02-20 2000-09-01 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation. HK1026148A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI000362A IT1289938B1 (it) 1997-02-20 1997-02-20 Preparazione farmaceutica comprendente liposomi liofilizzati in cui e' incapsulato un principio attivo altamente insolubile in acqua e
PCT/EP1998/000817 WO1998036736A1 (en) 1997-02-20 1998-02-12 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation

Publications (1)

Publication Number Publication Date
HK1026148A1 true HK1026148A1 (en) 2000-12-08

Family

ID=11376097

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00105485A HK1026148A1 (en) 1997-02-20 2000-09-01 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation.

Country Status (26)

Country Link
US (1) US6319517B1 (it)
EP (1) EP0981332B1 (it)
JP (1) JP4290767B2 (it)
KR (1) KR100496802B1 (it)
CN (1) CN1089581C (it)
AR (1) AR011681A1 (it)
AT (1) ATE285754T1 (it)
AU (1) AU744115B2 (it)
BG (1) BG64580B1 (it)
CA (1) CA2288958C (it)
CZ (1) CZ295998B6 (it)
DE (1) DE69828394T2 (it)
EA (1) EA001637B1 (it)
ES (1) ES2235320T3 (it)
GE (1) GEP20022734B (it)
HK (1) HK1026148A1 (it)
HU (1) HU225593B1 (it)
IL (1) IL131327A (it)
IT (1) IT1289938B1 (it)
PL (1) PL190628B1 (it)
PT (1) PT981332E (it)
SK (1) SK282931B6 (it)
TR (1) TR199902025T2 (it)
UA (1) UA70296A (it)
WO (1) WO1998036736A1 (it)
ZA (1) ZA981352B (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60012932T2 (de) * 1999-06-23 2005-08-18 Cornell Research Foundation, Inc. Entwässerung/rehydratisierung von markierten liposomen auf einer prüfeinrichtung
US6576460B1 (en) 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use
MXPA05007571A (es) * 2003-01-17 2005-11-17 Threshold Pharmaceuticals Inc Tratamiento para hiperplasia protatica benigna utilizando agentes energoliticos.
JP2008535921A (ja) 2005-04-12 2008-09-04 エラン・ファルマ・インターナショナル・リミテッド シクロスポリンを含むナノ粒子および放出調節された組成物
WO2008036979A2 (en) * 2006-09-22 2008-03-27 Guilford F Timothy Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non-histamine related inflammatory skin changes
CN101049504B (zh) * 2007-04-05 2010-05-19 广州立恩生物科技有限公司 一种脂质体药物载体及其制备方法
US9446147B2 (en) 2011-02-24 2016-09-20 The Ohio State University Membrane stabilizing compositions and methods
EP2768484B1 (en) 2011-10-21 2019-07-24 Jazz Pharmaceuticals Research LLC Lyophilized liposomes
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
JP5957610B2 (ja) * 2012-08-31 2016-07-27 チュンアン ユニバーシティー インダストリー アカデミック コアポレイション ファウンデイション 塞栓用のミクロスフェアの製造方法及び薬物含有ナノ輸送体が結合されたミクロスフェアの製造方法
US10722465B1 (en) 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
US11344497B1 (en) 2017-12-08 2022-05-31 Quicksilver Scientific, Inc. Mitochondrial performance enhancement nanoemulsion
KR102646145B1 (ko) 2018-05-31 2024-03-11 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모공 축소용 조성물
BR112020026635A2 (pt) * 2018-06-27 2021-04-20 Breath Therapeutics Gmbh composições inaláveis compreendendo imunosupressores macrocíclicos
BR112020026629A2 (pt) 2018-06-27 2021-03-23 Breath Therapeutics Gmbh Composições farmacêuticas na forma liofilizada
JP7079984B2 (ja) 2018-07-28 2022-06-03 エクソコバイオ インコーポレイテッド エキソソームの凍結乾燥方法
KR102163806B1 (ko) 2018-07-30 2020-10-07 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물
EA202092892A1 (ru) 2018-12-04 2021-05-27 Брес Терапьютикс Гмбх Ингаляционные композиции, содержащие макроциклические иммуносупрессанты
US11291702B1 (en) 2019-04-15 2022-04-05 Quicksilver Scientific, Inc. Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method
WO2020261158A1 (en) 2019-06-25 2020-12-30 Translatum Medicus Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
CN111358955B (zh) * 2020-04-01 2023-05-02 重庆理工大学 一种用于治疗脂质代谢疾病的炎症靶向的宾达利纳米粒、制备方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
FR2542749B1 (fr) * 1983-03-18 1985-07-12 Beghin Say Sa Copolymere allyloligosaccharide-acrylique salifie, procede de preparation du copolymere et application comme super-absorbant
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
US4963362A (en) * 1987-08-07 1990-10-16 Regents Of The University Of Minnesota Freeze-dried liposome mixture containing cyclosporin
US5683714A (en) * 1991-04-19 1997-11-04 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin pharmaceutical formulation
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
GB9320668D0 (en) * 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
CA2153251C (en) * 1993-11-05 1998-09-01 David Samuel Collins Liposome preparation and material encapsulation method

Also Published As

Publication number Publication date
EP0981332B1 (en) 2004-12-29
CZ292599A3 (cs) 2000-01-12
KR20000075479A (ko) 2000-12-15
EA199900751A1 (ru) 2000-10-30
WO1998036736A1 (en) 1998-08-27
AU744115B2 (en) 2002-02-14
BG103738A (en) 2000-05-31
CN1248163A (zh) 2000-03-22
HUP0001464A2 (hu) 2000-10-28
HU225593B1 (en) 2007-05-02
UA70296C2 (uk) 2004-10-15
EA001637B1 (ru) 2001-06-25
KR100496802B1 (ko) 2005-06-22
BG64580B1 (bg) 2005-08-31
UA70296A (uk) 2004-10-15
JP2001519776A (ja) 2001-10-23
ITMI970362A1 (it) 1998-08-20
GEP20022734B (en) 2002-07-25
IL131327A (en) 2004-07-25
PL190628B1 (pl) 2005-12-30
DE69828394T2 (de) 2005-12-08
JP4290767B2 (ja) 2009-07-08
CZ295998B6 (cs) 2005-12-14
SK111099A3 (en) 2000-05-16
IL131327A0 (en) 2001-01-28
IT1289938B1 (it) 1998-10-19
EP0981332A1 (en) 2000-03-01
ZA981352B (en) 1998-08-19
PT981332E (pt) 2005-05-31
US6319517B1 (en) 2001-11-20
TR199902025T2 (xx) 1999-11-22
ATE285754T1 (de) 2005-01-15
ES2235320T3 (es) 2005-07-01
SK282931B6 (sk) 2003-01-09
AR011681A1 (es) 2000-08-30
CA2288958C (en) 2007-08-21
DE69828394D1 (de) 2005-02-03
PL335207A1 (en) 2000-04-10
HUP0001464A3 (en) 2001-12-28
AU6496998A (en) 1998-09-09
CA2288958A1 (en) 1998-08-27
CN1089581C (zh) 2002-08-28

Similar Documents

Publication Publication Date Title
HK1026148A1 (en) Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation.
EP0645136A3 (en) Pharmaceutical preparation of the type: physiologically active substance with sustained release.
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
ZA969176B (en) Stable freeze-dried pharmaceutical formulation.
HUP0102833A3 (en) Cyclosporins, process for preparation thereof and their use
ZA979573B (en) (Alpha-aminophosphino) peptide derivatives, process for their preparation and their therapeutic applications.
ZA200201057B (en) Radiopharmaceutical products and their preparation procedure.
HK1019606A1 (en) Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
IL126714A (en) Use of cells, organs or components thereof for the preparation of a pharmaceutical composition for establishing selective immune downregulation
HK1040980A1 (zh) 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途
ZA200203294B (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them.
EP1002793A4 (en) PHYSIOLOGICALLY ACTIVE SUBSTANCES TKR2449, METHOD FOR THEIR PRODUCTION AND MICROORGANISMS
HK1049167A1 (en) Spherical telithromycin clusters, method for the producing and use thereof in the preparation of pharmaceutical forms.
MXPA02003270A (es) Peptido antigenico del virus de hepatitis e y metodos de elaboracion.
ZA976619B (en) Benzimidazole derivatives, their preparation and their therapeutic applications.
ZA987412B (en) 3-Arylsuccinamidohydroxamic acids, processes for their preparation, and drugs containing these substances.
HUP9700074A3 (en) Low molecular yeast active substance extract and process for preparing the same
ZA200300777B (en) Process for the preparation of peptide salts, their use and pharmaceutical preparations comprising the peptide salts.
SI0981332T1 (en) Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
HK1047037A1 (en) Pharmaceutical preparations containing nanosols ofchitosan, and their preparation.
ZA99168B (en) Pharmaceutical formulations and processes for their preparation.
IL124342A (en) Antineoplastic peptides, their preparation and different uses thereof
IL136230A0 (en) An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
EP0897988A4 (en) TKR1785'S PHYSIOLOGICALLY ACTIVE SUBSTANCES, THEIR PROCESS AND MICROBE

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150212